Conflicts of interest: E.L.N. is a BioLineRx employee, and P.B. is owner of Innovative Pharmaceutical Concepts Inc., which has a licensing agreement with BioLineRx.

Read the full text

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

References

1Hafner C, Vogt T. Seborrheic keratosis. J Dtsch Dermatol Ges 2008; 6: 664–77.
10.1111/j.1610-0387.2008.06788.x
CAS PubMed Web of Science® Google Scholar
2Otley CC, Roenigk RK. Medium-depth chemical peeling. Semin Cutan Med Surg 1996; 15: 145–54.
10.1016/S1085-5629(96)80005-8
CAS PubMed Web of Science® Google Scholar
3Yonei N, Kanazawa N, Ohtani T et al. Induction of PDGF-B in TCA-treated epidermal keratinocytes. Arch Dermatol Res 2007; 299: 433–40.
10.1007/s00403-007-0781-6
CAS PubMed Web of Science® Google Scholar
4Bhat RM, Vidya K, Kamath G. Topical formic acid puncture technique for the treatment of common warts. Int J Dermatol 2001; 40: 415–19.
10.1046/j.1365-4362.2001.01242.x
CAS PubMed Web of Science® Google Scholar
5 ASEAN Cosmetic Documents. Annex VI. List of preservatives allowed for use in cosmetic products. Available at: http://www.aseancosmetics.org/docdocs/Annexe_VI_%28Ref_No._Order%29_02_December_2009.pdf (last accessed 13 May 2015).
Google Scholar
6Herron MD, Bowen AR, Krueger GG. Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod. Int J Dermatol 2004; 43: 300–2.
10.1111/j.1365-4632.2004.02282.x
CAS PubMed Web of Science® Google Scholar
7Burkhart CG, Burkhart CN. Use of a keratolytic agent with occlusion for topical treatment of hyperkeratotic seborrheic keratoses. Skinmed 2008; 7: 15–18.
10.1111/j.1540-9740.2007.07221.x
PubMed Google Scholar
8Cuevas P, Angulo J, Salgüero I, Giménez-Gallego G. Clearance of seborrhoeic keratoses with topical dobesilate. BMJ Case Rep 2012; 2012: bcr0120125628.
10.1136/bcr.01.2012.5628
PubMed Google Scholar
9Thyssen JP, Zachariae C. Successful treatment of multiple seborrheic keratoses using acitretin. J Eur Acad Dermatol Venereol 2007; 21: 269–70.
10.1111/j.1468-3083.2006.01841.x
PubMed Web of Science® Google Scholar

Citing Literature

Volume173, Issue1

July 2015

Pages 247-249

Seborrhoeic keratosis removal in a multicentre phase I/II clinical trial using a novel topical formulation (BL-5010)

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Seborrhoeic keratosis removal in a multicentre phase I/II clinical trial using a novel topical formulation (BL-5010)

References

Citing Literature

References

Related

Information